Medicine and Dentistry
Angiomyolipoma
100%
Tuberous Sclerosis
85%
Analysis
57%
Neoplasm
42%
Rapamycin
42%
Patient
42%
Measurement
28%
Creatinine
28%
Drug Safety
28%
Prevalence
14%
Protein
14%
Serum
14%
Magnetic Resonance Imaging
14%
Autosomal Dominant Inheritance
14%
Morbidity
14%
Postoperative Complication
14%
Intention-to-Treat Analysis
14%
Combination Therapy
14%
Urine
14%
Skin Defect
14%
Population Research
14%
Systemic Disease
14%
Mammalian Target of Rapamycin Inhibitor
14%
Benign Tumor
14%
Therapeutic Procedure
14%
Plasma
14%
Arm
14%
Pharmacology, Toxicology and Pharmaceutical Science
Angiomyolipoma
100%
Tuberous Sclerosis
85%
Neoplasm
42%
Creatinine
28%
Mixed Model
28%
Protein
14%
Prevalence
14%
Morbidity
14%
Mammalian Target of Rapamycin Inhibitor
14%
Postoperative Complication
14%
Systemic Disease
14%
Benign Neoplasm
14%
Skin Defect
14%
Biochemistry, Genetics and Molecular Biology
Tuberous Sclerosis
85%
Volume
57%
Tumor Volume
28%
Reduction (Chemistry)
28%
Autosomal Dominant Inheritance
14%
Morbidity
14%
Blood Level
14%
Creatinine
14%
Prevalence
14%
Creatinine Blood Level
14%
Drug Safety
14%
Population Research
14%
Protein Urine Level
14%
Mammalian Target of Rapamycin
14%
Software
14%
Time
14%
Magnetic Resonance Imaging
14%